Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
2.120
-0.150 (-6.61%)
Oct 9, 2025, 4:00 PM EDT - Market closed
Immuron Employees
Immuron had 7 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$682,489
Profits / Employee
-$488,521
Market Cap
16.08M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 7 | 0 | - |
| Jun 30, 2024 | 7 | 1 | 16.67% |
| Jun 30, 2023 | 6 | 1 | 20.00% |
| Jun 30, 2022 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IMRN News
- 1 day ago - Immuron Submits IMM-529 IND to FDA - GlobeNewsWire
- 7 days ago - Immuron Letter to Shareholders – Projects Update - GlobeNewsWire
- 6 weeks ago - Immuron partners with InvestorHub - GlobeNewsWire
- 3 months ago - Immuron - FY25 global sales exceed projection, up 49% on prior year - GlobeNewsWire
- 4 months ago - Immuron Letter to Shareholders: Projects Update - GlobeNewsWire
- 6 months ago - Immuron Travelan® highest sales in history - GlobeNewsWire
- 7 months ago - Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) - GlobeNewsWire
- 9 months ago - Immuron Travelan® continued strong sales growth - GlobeNewsWire